Texas Capital Bancshares Inc Novartis Ag Transaction History

Texas Capital Bancshares Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$85.24 - $94.15 $207,729 - $229,443	-2,437 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$83.5 - $98.47 $2,171 - $2,560	-26 Reduced 1.06%	2,437 $208,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $85,408 - $103,306	-1,094 Reduced 30.76%	2,463 $233,000
Q4 2019 Jan 30, 2020	SELL	$84.35 - $95.37 $3,289 - $3,719	-39 Reduced 1.08%	3,557 $337,000
Q3 2019 Oct 28, 2019	SELL	$85.54 - $94.26 $107,609 - $118,579	-1,258 Reduced 25.92%	3,596 $312,000

Q2 2019 Jul 19, 2019	BUY	$75.4 - $92.8 $32,195 - $39,625	427 Added 9.65%	4,854 $443,000
Q1 2019 Apr 23, 2019	SELL	$75.32 - $86.15 $1,355 - $1,550	-18 Reduced 0.4%	4,427 $426,000
Q4 2018 Jan 29, 2019	BUY	$73.66 - $82.02 $59,369 - $66,108	806 Added 22.15%	4,445 $381,000
Q1 2018 Apr 25, 2018	SELL	$70.39 - $84.15 $1,900 - $2,272	-27 Reduced 0.74%	3,639 $294,000
Q3 2017 Oct 19, 2017	BUY	$74.14 - $77.27 $271,797 - $283,271	3,666	3,666 $315,000

1,351

140M

1.15M

866K

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $233B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Texas Capital Bancshares Inc, based on Form 13F filings with the SEC.

Stay updated on Texas Capital Bancshares Inc with notifications on news.